Standard Biotools (LAB) Non-Current Deferred Tax Liability (2014 - 2026)

Standard Biotools (LAB) has 13 years of Non-Current Deferred Tax Liability data on file, last reported at $823000.0 in Q1 2026.

• Non-Current Deferred Tax Liability for Q1 2026 came in at $823000.0, down 20.17% year-over-year; the trailing twelve-month figure through Mar 2026 was $823000.0 (down 20.17% YoY), and the FY2025 annual result was $810000.0, down 94.43% from the prior year.
• Non-Current Deferred Tax Liability climbed to $823000.0 in Q1 2026 per LAB's latest filing, from $810000.0 in the prior quarter.
• Over five years, Non-Current Deferred Tax Liability peaked at $14.5 million in Q4 2024 and troughed at $620000.0 in Q3 2022.
• A 5-year average of $1.9 million and a median of $1.0 million in 2025 frame the typical range for Non-Current Deferred Tax Liability.
• The sharpest annual moves came in 2024 and 2025: Non-Current Deferred Tax Liability soared 1629.01% in 2024, then sank 94.43% in 2025.
• A 5-year view of Non-Current Deferred Tax Liability shows it stood at $1.1 million in 2022, then slipped by 20.28% to $841000.0 in 2023, then soared by 1629.01% to $14.5 million in 2024, then slumped by 94.43% to $810000.0 in 2025, then climbed by 1.6% to $823000.0 in 2026.
• Business Quant data shows LAB's Non-Current Deferred Tax Liability at $823000.0 in Q1 2026, $810000.0 in Q4 2025, and $1.1 million in Q3 2025.